RESUMEN
Infectious pathogens may represent an environmental risk factor for chronic tic disorders (CTD). This cross-sectional study aimed to determine whether Mycoplasma pneumoniae (M. pneumoniae) IgG positivity is associated with the presence or severity of tics. We compared M. pneumoniae IgG positivity across three groups: children and adolescents (3-16â¯years) with CTD (CTD group; nâ¯=â¯302); siblings (3-10â¯years) of people with CTD who developed tics within a seven-year follow-up period (tic onset group; nâ¯=â¯51); siblings (4-10â¯years) who did not develop tics within the study period and were ≥10-years-old at their last assessment (unaffected group; nâ¯=â¯88). The relationship between M. pneumoniae IgG positivity and the presence and severity of tics was analysed using multilevel models controlling for site, family relatedness, sex, age, presence of comorbid obsessive-compulsive and/or attention-deficit/hyperactivity disorder and use of psychotropic medication. M. pneumoniae IgG positivity was not associated with the presence of CTD, or the first onset of tics as compared to siblings who remained unaffected. M. pneumoniae IgG positivity was associated with a higher tic severity score within the CTD group (ßâ¯=â¯2.64, s.e.â¯=â¯1.15, pâ¯=â¯0.02). It is possible that M. pneumoniae infection influences tic severity in CTD or, that having more severe tics, increases the risk of infection. However, it is more likely that the association observed in this study reflects a propensity toward enhanced immune responses in people with CTD and that, rather than a causal relationship, infection and greater tic severity are indirectly linked via shared underlying immune mechanisms.
Asunto(s)
Trastornos de Tic , Tics , Síndrome de Tourette , Adolescente , Niño , Estudios Transversales , Humanos , Inmunoglobulina G , Mycoplasma pneumoniae , Índice de Severidad de la Enfermedad , Trastornos de Tic/complicaciones , Tics/complicacionesRESUMEN
This study investigated whether vitamin D is associated with the presence or severity of chronic tic disorders and their psychiatric comorbidities. This cross-sectional study compared serum 25-hydroxyvitamin D [25(OH)D] (ng/ml) levels among three groups: children and adolescents (3-16 years) with CTD (n = 327); first-degree relatives (3-10 years) of individuals with CTD who were assessed for a period of up to 7 years for possible onset of tics and developed tics within this period (n = 31); and first-degree relatives who did not develop tics and were ≥ 10 years old at their last assessment (n = 93). The relationship between 25(OH)D and the presence and severity of tics, as well as comorbid obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD), were analysed controlling for age, sex, season, centre, latitude, family relatedness, and comorbidities. When comparing the CTD cohort to the unaffected cohort, the observed result was contrary to the one expected: a 10 ng/ml increase in 25(OH)D was associated with higher odds of having CTD (OR 2.08, 95% CI 1.27-3.42, p < 0.01). There was no association between 25(OH)D and tic severity. However, a 10 ng/ml increase in 25(OH)D was associated with lower odds of having comorbid ADHD within the CTD cohort (OR 0.55, 95% CI 0.36-0.84, p = 0.01) and was inversely associated with ADHD symptom severity (ß = - 2.52, 95% CI - 4.16-0.88, p < 0.01). In conclusion, lower vitamin D levels were not associated with a higher presence or severity of tics but were associated with the presence and severity of comorbid ADHD in children and adolescents with CTD.
Asunto(s)
Trastornos de Tic , Tics , Vitamina D , Adolescente , Trastorno por Déficit de Atención con Hiperactividad/psicología , Niño , Comorbilidad , Estudios Transversales , Humanos , Trastorno Obsesivo Compulsivo/epidemiología , Trastorno Obsesivo Compulsivo/psicología , Índice de Severidad de la Enfermedad , Trastornos de Tic/metabolismo , Trastornos de Tic/psicología , Tics/complicaciones , Tics/metabolismo , Síndrome de Tourette/psicología , Vitamina D/metabolismoRESUMEN
Technological leaps in DNA sequencing and synthesis are disrupting tenuous access and benefit-sharing (ABS) arrangements between 'users' and 'providers' of genetic resources. For some this signals a new era of open-source gene banks to address global challenges, but to others it threatens a new wave of unjust digital biopiracy. This paper explores the issue of digital sequence information (DSI) at the 2016 Cancun negotiations of the UN Convention on Biological Diversity and its Nagoya Protocol on ABS, and its continued relevance today. While some research has addressed potential solutions to digital sequencing and ABS, little attention has been paid to the problematization of the issue itself. This paper addresses this gap with a fine-grained view of the negotiations as an ethnographic site of contestation. We approach the Nagoya Protocol as an assemblage seeking to govern ABS. We trace how the unruly component of DSI threatens this already fragile assemblage by disrupting simplified notions of genetic resources, scientific discovery, and R&D. Our data from the negotiations reveals three major points of tension: the materiality of genetic resources; the problem's novelty; and the problem's urgency. Two opposing solutions raised in response to these contestations reveal underlying faultlines that we argue will continue to destabilise the broader ABS assemblage if left unresolved. Our attention to processes of assemblage (trans)formation offers insights to the historically fragile arrangements of ABS and, more broadly, assemblages of global environmental governance in the context of rapid technological change.
RESUMEN
The encephalitis lethargica (EL) epidemic swept the world from 1916 to 1926 and is estimated to have afflicted between 80,000 to one million people. EL is an unusual neurological illness that causes profound sleep disorders, devastating neurological sequalae and, in many cases, death. Though uncommon, EL is still occasionally diagnosed today when a patient presents with an acute or subacute encephalitic illness, where all other known causes of encephalitis have been excluded and criteria for EL are met. However, it is impossible to know whether recent cases of EL-like syndromes result from the same disease that caused the epidemic. After more than 100 years of research into potential pathogen triggers and the role of autoimmune processes, the aetiology of EL remains unknown. The epidemic approximately coincided with the 1918 H1N1 influenza pandemic but the evidence of a causal link is inconclusive. This article reviews the literature on the causes of EL with a focus on autoimmune mechanisms. In light of the current pandemic, we also consider the parallels between the EL epidemic and neurological manifestations of COVID-19. Understanding how pathogens and autoimmune processes can affect the brain may well help us understand the conundrum of EL and, more importantly, will guide the treatment of patients with suspected COVID-19-related neurological disease, as well as prepare us for any future epidemic of a neurological illness.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/virología , Encefalitis/inmunología , Encefalitis/virología , Pandemias/historia , Enfermedades Autoinmunes/historia , COVID-19 , Encefalitis/historia , Historia del Siglo XX , Humanos , Factores de RiesgoRESUMEN
BACKGROUND: Validity evidence based on test content is one of the five forms of validity evidence stipulated in the Standards for Educational and Psychological Testing developed by the American Educational Research Association, American Psychological Association, and National Council on Measurement in Education. In this paper, we describe the logic and theory underlying such evidence and describe traditional and modern methods for gathering and analyzing content validity data. METHOD: A comprehensive review of the literature and of the aforementioned Standards is presented. RESULTS: For educational tests and other assessments targeting knowledge and skill possessed by examinees, validity evidence based on test content is necessary for building a validity argument to support the use of a test for a particular purpose. CONCLUSIONS: By following the methods described in this article, practitioners have a wide arsenal of tools available for determining how well the content of an assessment is congruent with and appropriate for the specific testing purposes.
Asunto(s)
Evaluación Educacional/normas , Estudios de Validación como Asunto , Recolección de Datos , Evaluación Educacional/métodos , Escolaridad , Humanos , Matemática/educación , Modelos TeóricosRESUMEN
The recent review of taxation in Australia - the Henry tax review - has recommended that the federal government increase the taxes already levied on tobacco and alcohol. Tobacco and alcohol taxes are put forward as the best way of reducing the social harms caused by the use and misuse of these substances. Junk foods have the same pattern of misuse and the same social costs as tobacco and alcohol. The Henry tax review rejects the idea of taxing fatty foods, and to date the government has not implemented a tax on junk food. We propose that a tax on junk food be implemented as a tool to reduce consumption and address the obesity epidemic.
Asunto(s)
Alimentos/economía , Obesidad/prevención & control , Impuestos/legislación & jurisprudencia , Adulto , Australia/epidemiología , Niño , Humanos , Obesidad/epidemiologíaRESUMEN
BACKGROUND: Validity evidence based on test content is one of the five forms of validity evidence stipulated in the Standards for Educational and Psychological Testing developed by the American Educational Research Association, American Psychological Association, and National Council on Measurement in Education. In this paper, we describe the logic and theory underlying such evidence and describe traditional and modern methods for gathering and analyzing content validity data. METHOD: A comprehensive review of the literature and of the aforementioned Standards is presented. RESULTS: For educational tests and other assessments targeting knowledge and skill possessed by examinees, validity evidence based on test content is necessary for building a validity argument to support the use of a test for a particular purpose. CONCLUSIONS: By following the methods described in this article, practitioners have a wide arsenal of tools available for determining how well the content of an assessment is congruent with and appropriate for the specific testing purposes
ANTECEDENTES: la evidencia de validez basada en el contenido del test es una de las cinco formas de evidencias de validez estipuladas en los Standards for Educational and Psychological Testing de la American Educational Research Association. En este artículo describimos la lógica y teoría que subyace a tal fuente de evidencia, junto a métodos tradicionales y modernos para obtener y analizar los datos de validez de contenido. MÉTODO: una revisión comprehensiva de la bibliografía y de los mencionados Standards. RESULTADOS: para los tests educativos y otras evaluaciones de los conocimientos y habilidades que poseen los examinados, la evidencia de validez basada en el contenido del test es necesaria para elaborar un argumento de validez que apoye el uso de un test para un objetivo particular. CONCLUSIONES: siguiendo los métodos descritos en este artículo, los profesionales tienen un amplio arsenal de herramientas disponibles para determinar en qué medida el contenido de una evaluación es congruente y apropiado para los objetivos específicos de la evaluación
Asunto(s)
Humanos , Masculino , Femenino , Reproducibilidad de los Resultados/métodos , Reproducibilidad de los Resultados/normas , Reproducibilidad de los Resultados/tendencias , Reproducibilidad de los Resultados , Pruebas Psicológicas/estadística & datos numéricos , Pruebas Psicológicas/normas , Medicina Basada en la Evidencia/métodos , Reproducibilidad de los Resultados/instrumentación , Medicina Basada en la Evidencia/organización & administración , Medicina Basada en la Evidencia/estadística & datos numéricos , Medicina Basada en la Evidencia/normas , Práctica Clínica Basada en la Evidencia/métodos , Práctica Clínica Basada en la Evidencia/organización & administración , Práctica Clínica Basada en la Evidencia/normasRESUMEN
Aims. To compare the baseline characteristics of a population-based cohort of patients with ankylosing spondylitis (AS) commencing biological therapy to the reported characteristics of bDMARD randomised controlled trials (RCTs) participants. Methods. Descriptive analysis of AS participants in the Australian Rheumatology Association Database (ARAD) who were commencing bDMARD therapy. Results. Up to December 2008, 389 patients with AS were enrolled in ARAD. 354 (91.0%) had taken bDMARDs at some time, and 198 (55.9%) completed their entry questionnaire prior to or within 6 months of commencing bDMARDs. 131 (66.1%) had at least one comorbid condition, and 24 (6.8%) had a previous malignancy (15 nonmelanoma skin, 4 melanoma, 2 prostate, 1 breast, cervix, and bowel). Compared with RCT participants, ARAD participants were older, had longer disease duration and higher baseline disease activity. Conclusions. AS patients commencing bDMARDs in routine care are significantly different to RCT participants and have significant baseline comorbidities.